penicillamine has been researched along with bucillamine in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (16.13) | 18.7374 |
| 1990's | 14 (45.16) | 18.2507 |
| 2000's | 10 (32.26) | 29.6817 |
| 2010's | 1 (3.23) | 24.3611 |
| 2020's | 1 (3.23) | 2.80 |
| Authors | Studies |
|---|---|
| Funakoshi, T; Kiyozumi, M; Kojima, S; Shimada, H; Takahashi, Y | 1 |
| Kiyozumi, M; Kojima, S; Tagawa, Y; Takahashi, Y | 1 |
| Arimori, S; Ichikawa, Y; Shimizu, H | 1 |
| Hayashi, M; Matsunaga, K; Mita, S; Okahara, A | 1 |
| Matsunaga, K; Mita, S | 1 |
| Hayashi, M; Iso, T; Kasamatsu, S; Nakata, K; Sasano, M; Suda, H; Yamauchi, H | 1 |
| Ishikawa, K; Sakaguchi, M | 1 |
| Abe, C; Hayashi, M; Iso, T; Nozawa, RT; Shiokawa, Y; Yokota, T | 1 |
| Fujimura, K; Hikida, M; Horiuchi, M; Iso, T; Kuwano, M; Morikawa, K; Uemura, O; Yamauchi, H | 1 |
| Ohmori, H; Okimura, T; Yamamoto, I | 1 |
| Brooks, P; Conaghan, PG | 1 |
| Brooks, P; Conaghan, PG; Girgis, L | 1 |
| Hirohata, S; Lipsky, PE | 2 |
| Akamatsu, T; Matsubara, T; Mizuno, K; Saegusa, Y | 1 |
| Hirohata, S; Inoue, T; Ito, K; Iwamoto, S; Kawashima, C; Kisaki, T; Nishioka, Y; Sawada, T; Shinohara, S; Tohma, S | 1 |
| Adachi, K; Aoki, T; Hara, J; Kitano, A; Kobayashi, K; Matsumoto, T; Nakamura, S; Obata, A; Obayashi, M; Okabe, H; Okawa, K; Oshitani, N; Suzuki, N; Tabata, A; Watanabe, Y; Yasuda, K | 1 |
| Kim, HA; Song, YW | 1 |
| Kubo, T; Matsuno, H; Matsuura, K; Muraguchi, A; Nezuka, T; Sugiyama, E; Tsuji, H | 1 |
| Kumagai, S; Morinobu, A; Wang, Z | 1 |
| Aono, H; Horiuchi, M; Matsuoka, H; Mita, S; Nishimura, K; Takai, M; Tsuji, F | 1 |
| Hirata, D; Iwamoto, M; Kamimura, T; Kano, S; Masuyama, JI; Mimori, A; Minota, S; Okazaki, H; Sato, H; Yoshio, T | 1 |
| Fukushima, K; Inoue, T; Takeshita, K | 1 |
| Inoue, T; Nakaike, S; Sugimoto, M; Takeshita, K; Yamashita, M | 1 |
| Ohno, I | 1 |
| Aoyama, M; Asai, K; Fukuoka, M; Kobayashi, M; Kusabe, T; Otsuka, T; Tanikawa, T; Waguri-Nagaya, Y | 1 |
| Berezné, A; Guillevin, L; Mouthon, L; Poiraudeau, S | 1 |
| Akizawa, T; Koshikawa, S; Kuroki, A | 1 |
| Mimori, T; Yukawa, N | 1 |
| Baňasová, M; Hrabárová, E; Juránek, I; Nagy, M; Priesolová, E; Soltés, L; Valachová, K | 1 |
| Aryanian, Z; Daneshpazhooh, M; Etesami, I; Ghaedi, F; Goodarzi, A; Kalantari, Y; Mahmoudi, H; Tavakolpour, S; Teymourpour, A | 1 |
8 review(s) available for penicillamine and bucillamine
| Article | Year |
|---|---|
"Yellow nail syndrome" and rheumatoid arthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cysteine; Female; Humans; Male; Middle Aged; Nail Diseases; Nails; Penicillamine; Syndrome | 1991 |
Disease-modifying antirheumatic drugs, including methotrexate, gold, antimalarials, and D-penicillamine.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antimalarials; Antirheumatic Agents; Arthritis, Rheumatoid; Clinical Trials as Topic; Cysteine; Drug Therapy, Combination; Gold; Humans; Methotrexate; Penicillamine; Sulfasalazine | 1995 |
Disease-modifying antirheumatic drugs, including methotrexate, sulfasalazine, gold, antimalarials, and penicillamine.
Topics: Age Factors; Antimalarials; Arthritis, Rheumatoid; Clinical Trials as Topic; Cysteine; Digestive System; Gold; Humans; Liver; Methotrexate; Penicillamine; Sulfasalazine | 1994 |
[Drug induced nephrotic syndrome].
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Antirheumatic Agents; Cysteine; Humans; Nephrotic Syndrome; Organogold Compounds; Penicillamine | 2004 |
[Therapeutic management of systemic sclerosis].
Topics: Acute Kidney Injury; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Cyclophosphamide; Cysteine; Epoprostenol; Humans; Hypertension, Pulmonary; Immunosuppressive Agents; Interferons; Lung Diseases, Interstitial; Orthotic Devices; Penicillamine; Peripheral Blood Stem Cell Transplantation; Physical Therapy Modalities; Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies; Scleroderma, Systemic; Vasodilator Agents | 2006 |
[Drug-induced nephrotic syndrome].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Antineoplastic Agents; Antirheumatic Agents; Bone Density Conservation Agents; Cysteine; Diphosphonates; Gold Compounds; Humans; Interferons; Lithium Compounds; Nephrotic Syndrome; Pamidronate; Penicillamine | 2007 |
[Effect of disease modifying anti-rheumatic drugs on radiographic progression in rheumatoid arthritis].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Cysteine; Disease Progression; Drug Therapy, Combination; Gold Sodium Thiomalate; Humans; Isoxazoles; Leflunomide; Methotrexate; Penicillamine; Radiography; Randomized Controlled Trials as Topic; Sulfasalazine; Tacrolimus | 2009 |
Drug-induced pemphigus: A systematic review of 170 patients.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Antirheumatic Agents; Captopril; Cysteine; Drug-Related Side Effects and Adverse Reactions; Humans; Pemphigus; Penicillamine | 2021 |
2 trial(s) available for penicillamine and bucillamine
| Article | Year |
|---|---|
SA 96 (N-(2-mercapto-2-methylpropanoyl)-L-cysteine) in rheumatoid arthritis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Cysteine; Drug Eruptions; Elasticity; Female; Gold; Humans; Middle Aged; Penicillamine; Tensile Strength; Time Factors | 1986 |
A comparison between bucillamine and D-penicillamine in the treatment of rheumatoid arthritis.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Cysteine; Female; Humans; Male; Middle Aged; Penicillamine | 1997 |
21 other study(ies) available for penicillamine and bucillamine
| Article | Year |
|---|---|
Characterization of gold in urine and bile following administration of gold sodium thiomalate with chelating agents to rats.
Topics: Animals; Bile; Chelating Agents; Chromatography; Cysteine; Electrophoresis; Gold; Gold Sodium Thiomalate; Injections, Intravenous; Male; Penicillamine; Rats; Rats, Inbred Strains; Succimer; Unithiol | 1992 |
Protective effects of chelating agents against renal toxicity of gold sodium thiomalate in rats.
Topics: Animals; Chelating Agents; Cysteine; Glycosuria; Gold Sodium Thiomalate; Kidney Diseases; Male; Penicillamine; Rats; Rats, Inbred Strains; Succimer; Unithiol | 1991 |
Effect of bucillamine (SA96) on type II collagen induced arthritis in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Cell Division; Collagen; Cysteine; Dose-Response Relationship, Drug; Indomethacin; Male; Penicillamine; Rats; Synovial Membrane | 1991 |
Differences in the effects of the antirheumatic drugs, bucillamine and D-penicillamine, on mitogen-induced proliferation of mouse spleen cells.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Catalase; Cell Division; Cells, Cultured; Concanavalin A; Copper; Cysteine; Male; Mice; Mice, Inbred C3H; Penicillamine; Spleen; Structure-Activity Relationship | 1990 |
[Pharmacological studies on N-(2-mercapto-2-methylpropanoyl)-L-cysteine(SA96). IV. Effects of SA96 and its main metabolite, SA679, on denaturation of human gamma-globulin and adjuvant arthritis in rats].
Topics: Animals; Anti-Inflammatory Agents; Arthritis; Arthritis, Experimental; Cysteine; gamma-Globulins; Indomethacin; Male; Organ Size; Penicillamine; Protein Denaturation; Rats; Rats, Inbred Lew; Serum Albumin, Bovine | 1985 |
Effects of immunomodulators on candidacidal activity of normal peritoneal cells in BALB/c mice.
Topics: Animals; Anti-Inflammatory Agents; Candidiasis; Cysteine; Female; Hydrocortisone; Levamisole; Lipopolysaccharides; Macrophages; Mice; Mice, Inbred BALB C; Penicillamine | 1986 |
[Pharmacological studies of N-(2-mercapto-2-methylpropionyl)-L-cysteine (SA 96). VI. Effects on vitamin B6, metals and skin collagen in rats].
Topics: Animals; Anti-Inflammatory Agents; Body Weight; Collagen; Cysteine; Liver; Male; Metals; Penicillamine; Pyridoxine; Rats; Rats, Inbred Strains; Skin | 1985 |
SA96: an immunopharmacological profile in vitro.
Topics: Animals; Antibody Formation; Antibody-Producing Cells; Cattle; Concanavalin A; Cysteine; Dose-Response Relationship, Drug; Female; Fetal Blood; Lipopolysaccharides; Lymphocyte Activation; Lymphocytes; Mercaptoethanol; Mice; Mice, Inbred BALB C; Penicillamine; Spleen | 1982 |
Comparative inhibitory effects of bucillamine and D-penicillamine on the function of human B cells and T cells.
Topics: Adult; B-Lymphocytes; Cysteine; Humans; Immunoglobulin M; Interferon-gamma; Interleukin-6; Penicillamine; T-Lymphocytes | 1994 |
Inhibition of mitogen-induced response of human peripheral blood mononuclear cells by bucillamine, a new antirheumatic sulfhydryl drug.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cell Division; Copper; Copper Sulfate; Cysteine; DNA; Humans; Hydrogen Peroxide; Leukocytes, Mononuclear; Mitogens; Penicillamine; Phytohemagglutinins | 1994 |
[Analysis of the state of patients with rheumatoid arthritis using a personal computer].
Topics: Age Factors; Arthritis, Rheumatoid; Cysteine; Databases, Factual; Female; Gold Sodium Thiomalate; Humans; Male; Microcomputers; Middle Aged; Penicillamine; Quality of Life; Time Factors | 1993 |
Regulation of B cell function by bucillamine, a novel disease-modifying antirheumatic drug.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; B-Lymphocytes; Copper; Cysteine; Depression, Chemical; Humans; Immunoglobulin M; Lymphocyte Activation; Penicillamine | 1993 |
Effect of bucillamine on the rat trinitrobenzene sulfonic acid induced model of colitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis; Cysteine; Male; Penicillamine; Rats; Rats, Wistar; Trinitrobenzenes | 1996 |
Pharmacological effects of SA96 (bucillamine) and its metabolites as immunomodulating drugs--the disulfide structure of SA-96 metabolites plays a critical role in the pharmacological action of the drug.
Topics: Adjuvants, Immunologic; Adult; Aged; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Cells, Cultured; Cysteine; Disulfides; Female; Gas Chromatography-Mass Spectrometry; Humans; Interleukin-6; Interleukin-8; Male; Middle Aged; Penicillamine; Rats; Structure-Activity Relationship; Synovial Fluid | 1998 |
Bucillamine suppresses human Th1 cell development by a hydrogen peroxide-independent mechanism.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; CD4-Positive T-Lymphocytes; Cell Differentiation; Cells, Cultured; Cysteine; Flow Cytometry; Humans; Hydrogen Peroxide; Interferon-gamma; Interleukin-12; Interleukin-2; Interleukin-4; Leukocyte Common Antigens; Oxidants; Penicillamine; Th1 Cells | 2000 |
Effects of sulfhydryl compounds on interleukin-1-induced vascular endothelial growth factor production in human synovial stromal cells.
Topics: Acetylcysteine; Cells, Cultured; Cysteine; Endothelial Growth Factors; Humans; Interleukin-1; Lymphokines; Penicillamine; Stromal Cells; Sulfhydryl Compounds; Synovial Membrane; Tiopronin; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |
In vitro and in vivo inhibition of activation induced T cell apoptosis by bucillamine.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies; Antirheumatic Agents; Apoptosis; Arthritis, Rheumatoid; B-Lymphocytes; CD3 Complex; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cysteine; Dexamethasone; Enterotoxins; Flow Cytometry; Glucocorticoids; Hybridomas; In Vitro Techniques; Interleukin-2; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Penicillamine; Reactive Oxygen Species; Superantigens; Thymus Gland | 2000 |
Effects of KE-758; an active metabolite of the new anti-rheumatic drug KE-298, D-penicillamine, bucillamine and auranofin on the proliferation of murine lymphocytes, and the production of nitric oxide by murine macrophages.
Topics: Animals; Antirheumatic Agents; Auranofin; Cell Division; Cell Line; Concanavalin A; Cysteine; Female; Hydrogen Peroxide; In Vitro Techniques; Interferon-gamma; Ionomycin; Lipopolysaccharides; Lymphocyte Activation; Lymphocytes; Macrophages; Mice; Mice, Inbred DBA; Nitric Oxide; Penicillamine; Phenylpropionates; Recombinant Proteins; Tetradecanoylphorbol Acetate | 2001 |
KE-758, an active metabolite of the new anti-rheumatic drug KE-298, suppresses production of tumor necrosis factor-alpha and interleukin-1 beta in THP-1, a human monocyte cell line.
Topics: Antirheumatic Agents; Auranofin; Cell Line; Cysteine; Enzyme-Linked Immunosorbent Assay; Humans; Interferon-gamma; Interleukin-1; Lipopolysaccharides; Monocytes; Penicillamine; Phenylbutyrates; Phenylpropionates; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha | 2002 |
The inhibitory effect of disease-modifying anti-rheumatic drugs and steroids on gliostatin/platelet-derived endothelial cell growth factor production in human fibroblast-like synoviocytes.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cells; Cells, Cultured; Cysteine; Dexamethasone; Elbow; Female; Fibroblasts; Humans; Knee; Methotrexate; Middle Aged; Organogold Compounds; Orthopedic Procedures; Penicillamine; Phenylacetates; Sulfasalazine; Synovial Membrane; Thymidine Phosphorylase | 2005 |
Free-radical degradation of high-molecular-weight hyaluronan induced by ascorbate plus cupric ions. Testing of bucillamine and its SA981-metabolite as antioxidants.
Topics: Antioxidants; Antirheumatic Agents; Ascorbic Acid; Cations; Copper; Cysteine; Free Radicals; Hyaluronic Acid; Hydroxyl Radical; Molecular Weight; Oxidation-Reduction; Penicillamine; Peroxides; Viscosity | 2011 |